Difference between revisions of "Radiotherapy toxicity management"
Jump to navigation
Jump to search
m |
m (→Guidelines) |
||
| Line 12: | Line 12: | ||
'''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.''' | '''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.''' | ||
==ASCO== | ==ASCO== | ||
| − | *'''1999:''' Hensley et al. [https://doi.org/10.1200/jco.1999.17.10.3333 American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants] [https://pubmed.ncbi.nlm.nih.gov/10506637/ PubMed] | + | *'''2008:''' Hensley et al. [https://doi.org/10.1200/jco.2008.17.2627 American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants] [https://pubmed.ncbi.nlm.nih.gov/19018081/ PubMed] |
| + | **'''2002:''' Schuchter et al. [https://doi.org/10.1200/jco.2002.04.178 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology] [https://pubmed.ncbi.nlm.nih.gov/12065567/ PubMed] | ||
| + | **'''1999:''' Hensley et al. [https://doi.org/10.1200/jco.1999.17.10.3333 American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants] [https://pubmed.ncbi.nlm.nih.gov/10506637/ PubMed] | ||
[[Category:General reference pages]] | [[Category:General reference pages]] | ||
[[Category:Radiation]] | [[Category:Radiation]] | ||
[[Category:Supportive oncology]] | [[Category:Supportive oncology]] | ||
Revision as of 00:48, 26 October 2023
| Focus editor | Associate editor | ||
|---|---|---|---|
 |
Michael K. Rooney, MD MD Anderson Cancer Center Houston, TX, USA |
 |
Danielle S. Bitterman, MD Dana-Farber Cancer Institute Boston, MA, USA |
The purpose of this page is to address the management of toxicity from radiation therapy.
To be created!
Guidelines
Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.
ASCO
- 2008: Hensley et al. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants PubMed
- 2002: Schuchter et al. 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology PubMed
- 1999: Hensley et al. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants PubMed